Schedule 13G ownership disclosure

Lipocine Inc.

Security class unavailable · CUSIP: 53630X104

Event date: 2019-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,100,000
Percent of class
8.7400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000102
Form type
SC 13G
Filer
Lipocine Inc.
CIK
CIK 1535955
Filed
Nov 22, 2019
Reporting period
Nov 14, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub